Table 3.

Inhibition of C. neoformans ATCC 6895 growth in presence of selected compounds at 37 °C in the aerobic environment or in 5.5% CO₂.

Compound (3mM)	Growth inhibition (%) vs. control
	Air	5.5% CO2
30	42.9 ± 26.4**,#	13.3 ± 12.4
12	4.2 ± 5.9	0.0 ± 0.0
ETZ	25.6 ± 15.6**	8.2 ± 11.2

ETZ: ethoxyzolamide.

^**p < 0.01 vs. control (medium added with solvent alone).

^#p < 0.05 vs. compound 30 in 5.5% CO₂, assessed by Student’s t test.